Home       Market Dynamics     Macro Trends     Sector Trends     Company Insights     AI Investing     Strategies     Sign Up     Login         

Regeneron Pharmaceuticals (REGN) Stock Price Prediction and News Highlight
Fri. Jan 30, 2026

One Week Return: -1.61%, One Month Return: -4.2%, Three Month Return: 13.36%

Sector: Biotechnology

Recent developments in Regeneron's product pipeline highlight significant advancements, particularly in the growth of Dupixent and Eylea HD. The rising sales of Dupixent are compensating for Eylea's losses, showcasing a positive shift in the portfolio. Additionally, the company is focusing on enhancing its weight-loss and cholesterol-lowering drugs, which could provide competitive advantages in the pharmaceutical market. Overall, these factors suggest a promising trajectory for Regeneron's product/service development initiatives.

The price action of Regeneron Pharmaceuticals (REGN) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at -0.5 is modestly bearish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next. There is no clear direction for REGN since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.6, and the negative at -0.6 on 2026-01-30. The forces of Market Risk Appetite (-3.2), Stock Price Trend (-0.5), and Sector Price Trend (-0.1) will drive down the price. The forces of Valuation Sentiment (0.4), Price Level Sentiment (0.5), Sentiment towards Fundamentals (1), and Option Sentiment (1.5) will drive up the price.

The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band.

Earning Release: 2026-04-30 06:00, EPS: $41.74, P/E: 17.76

Sign up to reveice notifications on Market Movers
REGN
DateAttentionPriceStdDevPrice
Level
Change10 Day
Trend
Trend
Sentiment
Hourly
Trend
Sentiment
Hourly
StdDev
Market
Sentiment
ActionPFund.News
Sentiment
2026-01-300%(0%)      741.45 2.84%    25    -1.07%    -0.01% -0.5    -0.5    0.6%    -0.1    Short    55% 1    5.5   
2026-01-290%(0%)      749.44 2.74%    32    -0.22%    -0.05% -0.5    -0    1.1%    0.4    Short    55% 1.8    -1   
2026-01-280%(0%)      751.13 2.71%    33    -2.61%    -0.11% -0.3    -0.4    1%    0.9    Short    55% 2.5    -1   
2026-01-270%(0%)      771.25 2.64%    56    1.13%    0.04% 0.9    0.3    0.9%    1.3    Long    55% 3.4    -1   
2026-01-260%(0%)      762.65 2.72%    44    1.21%    -0.44% 0.3    0.2    0.7%    0.6    Long    55% 3.2    -1   
2026-01-250%(0%)    -0.5    0.2    0.1          3.2    -1   
2026-01-240%(0%)    -0.5    0.2    0.1          3.4    -1   
2026-01-230%(0%)      753.55 2.79%    32    -0.26%    -0.63% -0.5    0.1    0.8%    0.4    Wait    50% 3.4    -1   
2026-01-220%(0%)      755.51 2.78%    33    0.82%    -0.75% -1    0.2    1.2%    -0.2    Wait    50% 2.1    -1   
2026-01-210%(0%)      749.33 2.78%    24    2.12%    -0.35% -0.8    0.6    0.8%    -0.3    Wait    50% 0.7    -1   
 
Short is the preferred trading strategy with 55% chance of being right. Weak trend sentiment and negative hourly trend.

Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position.

Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force.

2026-01-30 17:12:48 Investor movements, including acquisitions of stock by financial institutions, indicate a positive sentiment towards Regeneron despite competitive pressures.
2026-01-30 17:12:48 Increased competition in the biopharmaceutical sector is posing challenges for Regeneron's product sales, particularly for its Eylea drug.
2026-01-30 17:12:48 There is a notable fluctuation in stock prices, alongside discussions around the valuation of Regeneron's stock based on recent earnings reports.
2026-01-30 17:12:48 Regeneron's strategy to enhance its products, particularly their weight-loss and cholesterol-lowering drugs, is seen as a pathway to gaining competitive advantages in the market.
2026-01-30 17:12:48 The company's quarterly earnings and financial performance are a major focus, highlighting both successes and challenges in meeting analyst estimates.
2026-01-30 13:49:56 The article references a significant potential market value of $150 billion for weight-loss drugs, indicating the growing interest and investment in this sector.
2026-01-30 13:49:56 Regeneron's confidence in the additional cholesterol-lowering benefits of its drug is positioned as a unique selling point that could enhance its market performance.
2026-01-30 13:49:56 The article discusses the competitive landscape of the obesity drug market, highlighting Regeneron's efforts to distinguish its product amidst various competitors.
2026-01-30 11:49:51 Regeneron's outlined increase in R&D spending indicates a strategy focused on innovation and development of new products.
2026-01-30 11:49:51 The rising competition in the market is a considerable concern for Regeneron as it impacts Eylea sales.
2026-01-30 11:49:51 Regeneron's plan for a $2 billion U.S. factory represents a significant investment in expansion and future growth.
2026-01-30 11:49:51 The increasing sales of Dupixent have offset the losses in Eylea, indicating a positive development in Regeneron's portfolio.
2026-01-30 11:49:51 Regeneron's lower sales of Eylea amid rising competition reflects a negative trend in earnings related to this specific product.


About   Contact Us  
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA